
ArchiMed preps Bomi auction
ArchiMed has hired Morgan Stanley to sell Bomi, an Italian logistics company serving the healthcare sector, according to three sources familiar with the situation.
The sale will kick off in the coming months, and teasers will be sent to both private equity firms and industry players, the sources said.
In 2020, the company generated EBITDA of EUR 27m from EUR 160m in revenues, one of the sources said. ArchiMed launched a EUR 70m takeover bid for Bomi in March 2019.
Bomi, ArchiMed and Morgan Stanley declined to comment.
The company has made a string of acquisitions this year. In November, it acquired Picking Farma, a Spanish company that has been providing logistics services to companies in the pharmaceuticals, veterinary and cosmetics sectors, for an undisclosed sum.
In June, Bomi acquired Line Express and ALX, a Brazilian company providing air transport services for pharmaceutical products with daily delivery to distributors, hospitals and clinics. And in January, it bought Italian Autotrasporti Gigliotti-Bergamin, a company specialising in the temperature-controlled transport of pharmaceuticals and related products, also for an undisclosed sum.
Established in 1985, Bomi provides transport, warehousing and supply chain management services for healthcare companies ranging from pharmaceutical and medical equipment manufacturers to hospitals, testing laboratories and outpatient service providers.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater